Theseus Pharmaceuticals Inc
NASDAQ:THRX
Theseus Pharmaceuticals Inc
Short-Term Investments
Theseus Pharmaceuticals Inc
Short-Term Investments Peer Comparison
Competitive Short-Term Investments Analysis
Latest Figures & CAGR of Competitors
Company | Short-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theseus Pharmaceuticals Inc
NASDAQ:THRX
|
Short-Term Investments
$103.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Short-Term Investments
$19B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
18%
|
CAGR 10-Years
7%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Short-Term Investments
$340m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-16%
|
|
Pfizer Inc
NYSE:PFE
|
Short-Term Investments
$11.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-10%
|
|
Merck & Co Inc
NYSE:MRK
|
Short-Term Investments
$40m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-44%
|
CAGR 10-Years
-38%
|
|
Eli Lilly and Co
NYSE:LLY
|
Short-Term Investments
$126.1m
|
CAGR 3-Years
37%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-21%
|
See Also
What is Theseus Pharmaceuticals Inc's Short-Term Investments?
Short-Term Investments
103.4m
USD
Based on the financial report for Dec 31, 2022, Theseus Pharmaceuticals Inc's Short-Term Investments amounts to 103.4m USD.